Trial Outcomes & Findings for Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty (NCT NCT00740480)

NCT ID: NCT00740480

Last Updated: 2009-08-25

Results Overview

Complete tissue approximation at one week.

Recruitment status

COMPLETED

Target enrollment

25 participants

Primary outcome timeframe

One week post surgery

Results posted on

2009-08-25

Participant Flow

Chart reviews and patient contact in clinic. Recruitment period from July 2008 to January 2009.

Participant milestones

Participant milestones
Measure
Septal Stapler Group
Adult population (ages 18-65) with clinically significant nasal septum deviation.
Overall Study
STARTED
25
Overall Study
COMPLETED
23
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Septal Stapler Group
Adult population (ages 18-65) with clinically significant nasal septum deviation.
Overall Study
Adverse Event
1
Overall Study
Physician Decision
1

Baseline Characteristics

Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Septal Stapler Group
n=25 Participants
Adult population (ages 18-65) with clinically significant nasal septum deviation.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
25 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age Continuous
39.9 years
STANDARD_DEVIATION 13.7 • n=5 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
Region of Enrollment
United States
25 participants
n=5 Participants

PRIMARY outcome

Timeframe: One week post surgery

Population: ITT

Complete tissue approximation at one week.

Outcome measures

Outcome measures
Measure
Septal Stapler Group
n=25 Participants
Adult population (ages 18-65) with clinically significant nasal septum deviation.
Coaptation (Tissue Approximation)
23 participants

SECONDARY outcome

Timeframe: One week post surgery

Population: ITT

None - no edema, erythema or purulence around the area of the staples Mild - slight erythema and/or edema in the region of one or more staple, limited to not greater than 2 mm from the staple Moderate - erythema and/or edema in the region of one or more staples, greater than 2 mm extension from the staples Severe - Generalized edema and/or erythema of the septum, or purulence and/or granulation tissue involved in one or more staples.

Outcome measures

Outcome measures
Measure
Septal Stapler Group
n=25 Participants
Adult population (ages 18-65) with clinically significant nasal septum deviation.
Tissue Reaction to Implant
Mild reaction
5 participants
Tissue Reaction to Implant
Moderate reaction
0 participants
Tissue Reaction to Implant
No reaction
18 participants
Tissue Reaction to Implant
Severe reaction
0 participants
Tissue Reaction to Implant
Cannot assess
2 participants

Adverse Events

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Gabriele Niederauer, PhD

ENTrigue Surgical, Inc.

Phone: 210-298-6398

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place